I think the most accurate statement that the consensus is that revenue is in jeopardy.
It's not an article talking about the science, it's reporting on analyst opinions. It also mentions itself that the opinions should be taken with a grain of salt.
Is anything I've said inaccurate?
Also, new threads pop up all the time, but not an issue for those around here when it's for "upramping" rather than "downramping".
I agree, there should be two threads only, one for charts and one for discussion (maybe one for banter as well). But that's not how MSBs HC threads are organised
News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-14
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |